<DOC>
	<DOCNO>NCT01184833</DOCNO>
	<brief_summary>Non-adherence treatment regimen common problem associate injectable drug ( e.g . Betaferon ) use multiple sclerosis patient . Certain patient omit single injection even totally discontinue therapy normally long-term . It therefore crucial identify factor significant effect regularity administration Betaferon risk premature discontinuation treatment order undertake appropriate preventive measure . This study conduct routine practice set aim identify risk . Pre-defined risk factor associate technical aspect treatment , support provide patient , stage disease possible adverse effect medication check quarterly basis questionnaire method . Monitoring omit dos prescribe medication ( Betaferon ) carry study nurse .</brief_summary>
	<brief_title>Evaluation Risk Factors Early Termination Injection Treatment With Betaferon Patients Suffering From Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Relapsingremitting multiple sclerosis Age &gt; /= 18 year Start treatment Betaferon earlier 60 day prior inclusion Synonymous contraindication Betaferon</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Interferon beta-1b</keyword>
	<keyword>Compliance treatment</keyword>
	<keyword>Premature treatment discontinuation</keyword>
</DOC>